GO:0018027 | peptidyl-lysine dimethylation | 11.32% (6/53) | 7.11 | 0.0 | 0.0 |
GO:0003682 | chromatin binding | 22.64% (12/53) | 3.76 | 0.0 | 0.0 |
GO:0006996 | organelle organization | 37.74% (20/53) | 2.27 | 0.0 | 1e-06 |
GO:0048513 | animal organ development | 24.53% (13/53) | 3.11 | 0.0 | 1e-06 |
GO:0051570 | regulation of histone H3-K9 methylation | 11.32% (6/53) | 5.57 | 0.0 | 1e-06 |
GO:0051052 | regulation of DNA metabolic process | 18.87% (10/53) | 3.75 | 0.0 | 1e-06 |
GO:0018022 | peptidyl-lysine methylation | 13.21% (7/53) | 4.85 | 0.0 | 1e-06 |
GO:0018205 | peptidyl-lysine modification | 16.98% (9/53) | 3.87 | 0.0 | 2e-06 |
GO:0022412 | cellular process involved in reproduction in multicellular organism | 20.75% (11/53) | 3.22 | 0.0 | 4e-06 |
GO:0000183 | rDNA heterochromatin formation | 7.55% (4/53) | 7.0 | 0.0 | 5e-06 |
GO:0006479 | protein methylation | 13.21% (7/53) | 4.43 | 0.0 | 5e-06 |
GO:0008213 | protein alkylation | 13.21% (7/53) | 4.43 | 0.0 | 5e-06 |
GO:0043414 | macromolecule methylation | 15.09% (8/53) | 3.98 | 0.0 | 5e-06 |
GO:1900114 | positive regulation of histone H3-K9 trimethylation | 5.66% (3/53) | 8.53 | 0.0 | 5e-06 |
GO:0006357 | regulation of transcription by RNA polymerase II | 24.53% (13/53) | 2.77 | 0.0 | 6e-06 |
GO:0040029 | epigenetic regulation of gene expression | 13.21% (7/53) | 4.3 | 0.0 | 7e-06 |
GO:0034968 | histone lysine methylation | 11.32% (6/53) | 4.77 | 0.0 | 9e-06 |
GO:0140718 | facultative heterochromatin formation | 9.43% (5/53) | 5.34 | 0.0 | 1.5e-05 |
GO:0016043 | cellular component organization | 47.17% (25/53) | 1.53 | 0.0 | 1.5e-05 |
GO:0036123 | histone H3-K9 dimethylation | 5.66% (3/53) | 7.94 | 0.0 | 1.7e-05 |
GO:0043967 | histone H4 acetylation | 9.43% (5/53) | 5.26 | 0.0 | 1.7e-05 |
GO:0000785 | chromatin | 15.09% (8/53) | 3.6 | 0.0 | 2.1e-05 |
GO:0016571 | histone methylation | 11.32% (6/53) | 4.5 | 0.0 | 2.1e-05 |
GO:0043170 | macromolecule metabolic process | 54.72% (29/53) | 1.29 | 0.0 | 2.1e-05 |
GO:0044260 | cellular macromolecule metabolic process | 33.96% (18/53) | 1.95 | 0.0 | 2.2e-05 |
GO:1900112 | regulation of histone H3-K9 trimethylation | 5.66% (3/53) | 7.65 | 0.0 | 2.5e-05 |
GO:0051276 | chromosome organization | 15.09% (8/53) | 3.55 | 0.0 | 2.6e-05 |
GO:0032991 | protein-containing complex | 39.62% (21/53) | 1.68 | 0.0 | 3e-05 |
GO:0071840 | cellular component organization or biogenesis | 47.17% (25/53) | 1.44 | 1e-06 | 3.3e-05 |
GO:0003674 | molecular_function | 90.57% (48/53) | 0.6 | 1e-06 | 3.7e-05 |
GO:0031325 | positive regulation of cellular metabolic process | 32.08% (17/53) | 1.95 | 1e-06 | 3.7e-05 |
GO:0031060 | regulation of histone methylation | 11.32% (6/53) | 4.26 | 1e-06 | 3.8e-05 |
GO:0016570 | histone modification | 15.09% (8/53) | 3.44 | 1e-06 | 3.8e-05 |
GO:0032259 | methylation | 15.09% (8/53) | 3.41 | 1e-06 | 4.1e-05 |
GO:0110165 | cellular anatomical entity | 90.57% (48/53) | 0.59 | 1e-06 | 4.2e-05 |
GO:0018193 | peptidyl-amino acid modification | 18.87% (10/53) | 2.86 | 1e-06 | 4.6e-05 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 35.85% (19/53) | 1.74 | 1e-06 | 5.8e-05 |
GO:0051173 | positive regulation of nitrogen compound metabolic process | 30.19% (16/53) | 1.96 | 2e-06 | 6.5e-05 |
GO:0035162 | embryonic hemopoiesis | 5.66% (3/53) | 7.02 | 2e-06 | 6.6e-05 |
GO:0005575 | cellular_component | 90.57% (48/53) | 0.57 | 2e-06 | 6.8e-05 |
GO:0070828 | heterochromatin organization | 9.43% (5/53) | 4.68 | 2e-06 | 6.8e-05 |
GO:0031507 | heterochromatin formation | 9.43% (5/53) | 4.69 | 2e-06 | 6.9e-05 |
GO:0007458 | progression of morphogenetic furrow involved in compound eye morphogenesis | 3.77% (2/53) | 9.53 | 2e-06 | 7.1e-05 |
GO:0009994 | oocyte differentiation | 3.77% (2/53) | 9.53 | 2e-06 | 7.1e-05 |
GO:0000122 | negative regulation of transcription by RNA polymerase II | 13.21% (7/53) | 3.54 | 2e-06 | 8.6e-05 |
GO:0006325 | chromatin organization | 13.21% (7/53) | 3.53 | 2e-06 | 8.8e-05 |
GO:0045814 | negative regulation of gene expression, epigenetic | 9.43% (5/53) | 4.55 | 2e-06 | 8.8e-05 |
GO:0090304 | nucleic acid metabolic process | 30.19% (16/53) | 1.87 | 3e-06 | 0.000123 |
GO:0010604 | positive regulation of macromolecule metabolic process | 30.19% (16/53) | 1.85 | 4e-06 | 0.000146 |
GO:0003677 | DNA binding | 30.19% (16/53) | 1.84 | 5e-06 | 0.00016 |
GO:0046293 | formaldehyde biosynthetic process | 3.77% (2/53) | 8.94 | 5e-06 | 0.000176 |
GO:0045322 | unmethylated CpG binding | 3.77% (2/53) | 8.94 | 5e-06 | 0.000176 |
GO:0106363 | protein-cysteine methyltransferase activity | 3.77% (2/53) | 8.94 | 5e-06 | 0.000176 |
GO:0009893 | positive regulation of metabolic process | 32.08% (17/53) | 1.73 | 6e-06 | 0.000178 |
GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 24.53% (13/53) | 2.1 | 6e-06 | 0.000199 |
GO:0031056 | regulation of histone modification | 11.32% (6/53) | 3.71 | 6e-06 | 0.000201 |
GO:2000036 | regulation of stem cell population maintenance | 5.66% (3/53) | 6.3 | 8e-06 | 0.000228 |
GO:0046292 | formaldehyde metabolic process | 5.66% (3/53) | 6.25 | 8e-06 | 0.000249 |
GO:0016573 | histone acetylation | 9.43% (5/53) | 4.16 | 9e-06 | 0.00026 |
GO:0140097 | catalytic activity, acting on DNA | 11.32% (6/53) | 3.63 | 9e-06 | 0.000264 |
GO:2001141 | regulation of RNA biosynthetic process | 30.19% (16/53) | 1.74 | 1.1e-05 | 0.000265 |
GO:0006475 | internal protein amino acid acetylation | 9.43% (5/53) | 4.14 | 1e-05 | 0.000266 |
GO:0018393 | internal peptidyl-lysine acetylation | 9.43% (5/53) | 4.14 | 1e-05 | 0.000266 |
GO:1903506 | regulation of nucleic acid-templated transcription | 30.19% (16/53) | 1.74 | 1.1e-05 | 0.000267 |
GO:0008150 | biological_process | 88.68% (47/53) | 0.53 | 1.1e-05 | 0.000267 |
GO:0018394 | peptidyl-lysine acetylation | 9.43% (5/53) | 4.13 | 1e-05 | 0.000267 |
GO:0018024 | histone-lysine N-methyltransferase activity | 7.55% (4/53) | 4.93 | 1e-05 | 0.000269 |
GO:0005488 | binding | 79.25% (42/53) | 0.66 | 1.2e-05 | 0.000269 |
GO:0090618 | DNA clamp unloading | 3.77% (2/53) | 8.53 | 1.1e-05 | 0.00027 |
GO:1905088 | positive regulation of synaptonemal complex assembly | 3.77% (2/53) | 8.53 | 1.1e-05 | 0.00027 |
GO:1905642 | negative regulation of DNA methylation | 3.77% (2/53) | 8.53 | 1.1e-05 | 0.00027 |
GO:0006355 | regulation of DNA-templated transcription | 30.19% (16/53) | 1.75 | 1e-05 | 0.000273 |
GO:0009987 | cellular process | 81.13% (43/53) | 0.64 | 1.2e-05 | 0.000273 |
GO:0006139 | nucleobase-containing compound metabolic process | 32.08% (17/53) | 1.67 | 1e-05 | 0.000276 |
GO:0048522 | positive regulation of cellular process | 37.74% (20/53) | 1.45 | 1.3e-05 | 0.000294 |
GO:0008094 | ATP-dependent activity, acting on DNA | 9.43% (5/53) | 4.05 | 1.3e-05 | 0.000301 |
GO:0006473 | protein acetylation | 9.43% (5/53) | 4.03 | 1.4e-05 | 0.00031 |
GO:0016278 | lysine N-methyltransferase activity | 7.55% (4/53) | 4.76 | 1.5e-05 | 0.000329 |
GO:0016279 | protein-lysine N-methyltransferase activity | 7.55% (4/53) | 4.76 | 1.5e-05 | 0.000329 |
GO:0030097 | hemopoiesis | 7.55% (4/53) | 4.73 | 1.6e-05 | 0.000349 |
GO:0045944 | positive regulation of transcription by RNA polymerase II | 13.21% (7/53) | 3.1 | 1.7e-05 | 0.000356 |
GO:0071704 | organic substance metabolic process | 66.04% (35/53) | 0.84 | 1.7e-05 | 0.000357 |
GO:0090173 | regulation of synaptonemal complex assembly | 3.77% (2/53) | 8.2 | 1.8e-05 | 0.000369 |
GO:0044238 | primary metabolic process | 60.38% (32/53) | 0.92 | 1.8e-05 | 0.000372 |
GO:0042054 | histone methyltransferase activity | 7.55% (4/53) | 4.66 | 2e-05 | 0.000404 |
GO:0010556 | regulation of macromolecule biosynthetic process | 32.08% (17/53) | 1.59 | 2.1e-05 | 0.000427 |
GO:1903046 | meiotic cell cycle process | 13.21% (7/53) | 3.01 | 2.5e-05 | 0.000495 |
GO:0060255 | regulation of macromolecule metabolic process | 39.62% (21/53) | 1.33 | 2.6e-05 | 0.000509 |
GO:0035097 | histone methyltransferase complex | 7.55% (4/53) | 4.54 | 2.8e-05 | 0.00051 |
GO:0140513 | nuclear protein-containing complex | 18.87% (10/53) | 2.31 | 2.7e-05 | 0.000511 |
GO:0051171 | regulation of nitrogen compound metabolic process | 37.74% (20/53) | 1.37 | 2.7e-05 | 0.000512 |
GO:0061860 | DNA clamp unloader activity | 3.77% (2/53) | 7.94 | 2.7e-05 | 0.000517 |
GO:0035640 | exploration behavior | 3.77% (2/53) | 7.94 | 2.7e-05 | 0.000517 |
GO:0031057 | negative regulation of histone modification | 7.55% (4/53) | 4.52 | 2.9e-05 | 0.000536 |
GO:0051252 | regulation of RNA metabolic process | 30.19% (16/53) | 1.61 | 3.4e-05 | 0.000625 |
GO:0043543 | protein acylation | 9.43% (5/53) | 3.75 | 3.6e-05 | 0.00065 |
GO:0071440 | regulation of histone H3-K14 acetylation | 3.77% (2/53) | 7.72 | 3.8e-05 | 0.00065 |
GO:1901674 | regulation of histone H3-K27 acetylation | 3.77% (2/53) | 7.72 | 3.8e-05 | 0.00065 |
GO:0008276 | protein methyltransferase activity | 7.55% (4/53) | 4.43 | 3.7e-05 | 0.000651 |
GO:0006807 | nitrogen compound metabolic process | 54.72% (29/53) | 0.97 | 3.7e-05 | 0.000656 |
GO:0051567 | histone H3-K9 methylation | 5.66% (3/53) | 5.53 | 3.9e-05 | 0.000666 |
GO:0031323 | regulation of cellular metabolic process | 39.62% (21/53) | 1.28 | 4.2e-05 | 0.000712 |
GO:0008170 | N-methyltransferase activity | 7.55% (4/53) | 4.36 | 4.5e-05 | 0.000752 |
GO:0035075 | response to ecdysone | 3.77% (2/53) | 7.53 | 5e-05 | 0.00081 |
GO:0044648 | histone H3-K4 dimethylation | 3.77% (2/53) | 7.53 | 5e-05 | 0.00081 |
GO:0048172 | regulation of short-term neuronal synaptic plasticity | 3.77% (2/53) | 7.53 | 5e-05 | 0.00081 |
GO:0006275 | regulation of DNA replication | 7.55% (4/53) | 4.31 | 5.1e-05 | 0.00082 |
GO:0048534 | hematopoietic or lymphoid organ development | 7.55% (4/53) | 4.32 | 5e-05 | 0.000829 |
GO:0031324 | negative regulation of cellular metabolic process | 22.64% (12/53) | 1.93 | 5.3e-05 | 0.000832 |
GO:0044030 | regulation of DNA methylation | 5.66% (3/53) | 5.36 | 5.6e-05 | 0.000871 |
GO:0080188 | gene silencing by RNA-directed DNA methylation | 5.66% (3/53) | 5.33 | 5.9e-05 | 0.000896 |
GO:0034708 | methyltransferase complex | 7.55% (4/53) | 4.26 | 5.8e-05 | 0.000899 |
GO:0009658 | chloroplast organization | 11.32% (6/53) | 3.15 | 5.8e-05 | 0.000901 |
GO:0031391 | Elg1 RFC-like complex | 3.77% (2/53) | 7.36 | 6.5e-05 | 0.000912 |
GO:0033553 | rDNA heterochromatin | 3.77% (2/53) | 7.36 | 6.5e-05 | 0.000912 |
GO:0061029 | eyelid development in camera-type eye | 3.77% (2/53) | 7.36 | 6.5e-05 | 0.000912 |
GO:0090241 | negative regulation of histone H4 acetylation | 3.77% (2/53) | 7.36 | 6.5e-05 | 0.000912 |
GO:0042573 | retinoic acid metabolic process | 3.77% (2/53) | 7.36 | 6.5e-05 | 0.000912 |
GO:0010468 | regulation of gene expression | 33.96% (18/53) | 1.41 | 6.1e-05 | 0.000929 |
GO:0061647 | histone H3-K9 modification | 5.66% (3/53) | 5.3 | 6.2e-05 | 0.00093 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 15.09% (8/53) | 2.54 | 6.3e-05 | 0.000934 |
GO:0010564 | regulation of cell cycle process | 13.21% (7/53) | 2.79 | 6.4e-05 | 0.00095 |
GO:0080090 | regulation of primary metabolic process | 37.74% (20/53) | 1.28 | 7e-05 | 0.000988 |
GO:0044237 | cellular metabolic process | 60.38% (32/53) | 0.83 | 7.1e-05 | 0.00099 |
GO:0000930 | gamma-tubulin complex | 3.77% (2/53) | 7.2 | 8.1e-05 | 0.001094 |
GO:0030466 | silent mating-type cassette heterochromatin formation | 3.77% (2/53) | 7.2 | 8.1e-05 | 0.001094 |
GO:0097692 | histone H3-K4 monomethylation | 3.77% (2/53) | 7.2 | 8.1e-05 | 0.001094 |
GO:0005515 | protein binding | 64.15% (34/53) | 0.76 | 9.4e-05 | 0.001269 |
GO:0003676 | nucleic acid binding | 35.85% (19/53) | 1.3 | 9.7e-05 | 0.001281 |
GO:0008172 | S-methyltransferase activity | 3.77% (2/53) | 7.07 | 9.8e-05 | 0.001286 |
GO:0030728 | ovulation | 3.77% (2/53) | 7.07 | 9.8e-05 | 0.001286 |
GO:0008152 | metabolic process | 66.04% (35/53) | 0.73 | 9.6e-05 | 0.001286 |
GO:0048518 | positive regulation of biological process | 39.62% (21/53) | 1.2 | 0.0001 | 0.001292 |
GO:0006259 | DNA metabolic process | 15.09% (8/53) | 2.44 | 0.000104 | 0.001334 |
GO:0006338 | chromatin remodeling | 9.43% (5/53) | 3.42 | 0.000104 | 0.001339 |
GO:0051726 | regulation of cell cycle | 15.09% (8/53) | 2.42 | 0.000111 | 0.001401 |
GO:0032451 | demethylase activity | 5.66% (3/53) | 5.0 | 0.000116 | 0.001457 |
GO:0009657 | plastid organization | 11.32% (6/53) | 2.96 | 0.000117 | 0.001459 |
GO:0007290 | spermatid nucleus elongation | 3.77% (2/53) | 6.94 | 0.000118 | 0.001464 |
GO:2000736 | regulation of stem cell differentiation | 5.66% (3/53) | 4.98 | 0.000121 | 0.001477 |
GO:0051574 | positive regulation of histone H3-K9 methylation | 5.66% (3/53) | 4.98 | 0.000121 | 0.001477 |
GO:0031326 | regulation of cellular biosynthetic process | 32.08% (17/53) | 1.37 | 0.000144 | 0.001746 |
GO:0006346 | DNA methylation-dependent heterochromatin formation | 5.66% (3/53) | 4.88 | 0.000148 | 0.001788 |
GO:0048523 | negative regulation of cellular process | 30.19% (16/53) | 1.43 | 0.000151 | 0.001812 |
GO:0019222 | regulation of metabolic process | 41.51% (22/53) | 1.11 | 0.000157 | 0.001869 |
GO:0022402 | cell cycle process | 16.98% (9/53) | 2.15 | 0.000167 | 0.001968 |
GO:0051573 | negative regulation of histone H3-K9 methylation | 3.77% (2/53) | 6.62 | 0.000187 | 0.002152 |
GO:0044666 | MLL3/4 complex | 3.77% (2/53) | 6.62 | 0.000187 | 0.002152 |
GO:0045776 | negative regulation of blood pressure | 3.77% (2/53) | 6.62 | 0.000187 | 0.002152 |
GO:0007276 | gamete generation | 9.43% (5/53) | 3.24 | 0.000187 | 0.002189 |
GO:0043984 | histone H4-K16 acetylation | 3.77% (2/53) | 6.53 | 0.000214 | 0.002394 |
GO:1903341 | regulation of meiotic DNA double-strand break formation | 3.77% (2/53) | 6.53 | 0.000214 | 0.002394 |
GO:0097746 | blood vessel diameter maintenance | 3.77% (2/53) | 6.53 | 0.000214 | 0.002394 |
GO:0009889 | regulation of biosynthetic process | 32.08% (17/53) | 1.33 | 0.000213 | 0.002434 |
GO:0007281 | germ cell development | 7.55% (4/53) | 3.75 | 0.00023 | 0.002562 |
GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 16.98% (9/53) | 2.08 | 0.00024 | 0.002651 |
GO:0051054 | positive regulation of DNA metabolic process | 7.55% (4/53) | 3.73 | 0.000243 | 0.002663 |
GO:0033043 | regulation of organelle organization | 13.21% (7/53) | 2.47 | 0.000249 | 0.002719 |
GO:0019239 | deaminase activity | 3.77% (2/53) | 6.36 | 0.000272 | 0.002844 |
GO:0046974 | histone methyltransferase activity (H3-K9 specific) | 3.77% (2/53) | 6.36 | 0.000272 | 0.002844 |
GO:0048066 | developmental pigmentation | 3.77% (2/53) | 6.36 | 0.000272 | 0.002844 |
GO:0048188 | Set1C/COMPASS complex | 3.77% (2/53) | 6.36 | 0.000272 | 0.002844 |
GO:0090239 | regulation of histone H4 acetylation | 3.77% (2/53) | 6.36 | 0.000272 | 0.002844 |
GO:0051172 | negative regulation of nitrogen compound metabolic process | 20.75% (11/53) | 1.78 | 0.00028 | 0.002908 |
GO:0048856 | anatomical structure development | 41.51% (22/53) | 1.06 | 0.000272 | 0.002929 |
GO:0048568 | embryonic organ development | 5.66% (3/53) | 4.59 | 0.000271 | 0.002943 |
GO:0031048 | small non-coding RNA-dependent heterochromatin formation | 5.66% (3/53) | 4.56 | 0.000289 | 0.002985 |
GO:0046483 | heterocycle metabolic process | 32.08% (17/53) | 1.28 | 0.000302 | 0.0031 |
GO:0140719 | constitutive heterochromatin formation | 3.77% (2/53) | 6.28 | 0.000304 | 0.0031 |
GO:1902679 | negative regulation of RNA biosynthetic process | 15.09% (8/53) | 2.2 | 0.000319 | 0.00322 |
GO:1903507 | negative regulation of nucleic acid-templated transcription | 15.09% (8/53) | 2.2 | 0.000319 | 0.00322 |
GO:1901363 | heterocyclic compound binding | 47.17% (25/53) | 0.93 | 0.000327 | 0.003277 |
GO:2000615 | regulation of histone H3-K9 acetylation | 3.77% (2/53) | 6.2 | 0.000337 | 0.003343 |
GO:0035296 | regulation of tube diameter | 3.77% (2/53) | 6.2 | 0.000337 | 0.003343 |
GO:0010605 | negative regulation of macromolecule metabolic process | 22.64% (12/53) | 1.64 | 0.000345 | 0.003402 |
GO:0043226 | organelle | 64.15% (34/53) | 0.68 | 0.000357 | 0.003499 |
GO:0097159 | organic cyclic compound binding | 47.17% (25/53) | 0.92 | 0.000366 | 0.003567 |
GO:0030521 | androgen receptor signaling pathway | 3.77% (2/53) | 6.13 | 0.000373 | 0.003589 |
GO:0018026 | peptidyl-lysine monomethylation | 3.77% (2/53) | 6.13 | 0.000373 | 0.003589 |
GO:0065007 | biological regulation | 60.38% (32/53) | 0.72 | 0.000386 | 0.0037 |
GO:0070988 | demethylation | 5.66% (3/53) | 4.38 | 0.000411 | 0.003855 |
GO:0048146 | positive regulation of fibroblast proliferation | 3.77% (2/53) | 6.07 | 0.00041 | 0.003858 |
GO:0002449 | lymphocyte mediated immunity | 3.77% (2/53) | 6.07 | 0.00041 | 0.003858 |
GO:0022414 | reproductive process | 37.74% (20/53) | 1.1 | 0.000406 | 0.003868 |
GO:0003712 | transcription coregulator activity | 9.43% (5/53) | 2.98 | 0.000435 | 0.004053 |
GO:0035150 | regulation of tube size | 3.77% (2/53) | 6.0 | 0.000448 | 0.004109 |
GO:0016922 | nuclear receptor binding | 5.66% (3/53) | 4.34 | 0.000446 | 0.004116 |
GO:0070192 | chromosome organization involved in meiotic cell cycle | 5.66% (3/53) | 4.34 | 0.000446 | 0.004116 |
GO:0008270 | zinc ion binding | 11.32% (6/53) | 2.6 | 0.000459 | 0.004165 |
GO:0034641 | cellular nitrogen compound metabolic process | 32.08% (17/53) | 1.23 | 0.000458 | 0.00418 |
GO:0050789 | regulation of biological process | 56.6% (30/53) | 0.75 | 0.000473 | 0.004244 |
GO:0042393 | histone binding | 7.55% (4/53) | 3.47 | 0.000472 | 0.004264 |
GO:0061629 | RNA polymerase II-specific DNA-binding transcription factor binding | 7.55% (4/53) | 3.46 | 0.000486 | 0.00434 |
GO:0033169 | histone H3-K9 demethylation | 3.77% (2/53) | 5.94 | 0.000488 | 0.004341 |
GO:0006725 | cellular aromatic compound metabolic process | 33.96% (18/53) | 1.17 | 0.000501 | 0.004433 |
GO:0032411 | positive regulation of transporter activity | 5.66% (3/53) | 4.28 | 0.000509 | 0.004476 |
GO:0090068 | positive regulation of cell cycle process | 7.55% (4/53) | 3.44 | 0.000514 | 0.004495 |
GO:0000792 | heterochromatin | 5.66% (3/53) | 4.27 | 0.000522 | 0.004545 |
GO:0032454 | histone H3-methyl-lysine-9 demethylase activity | 3.77% (2/53) | 5.88 | 0.00053 | 0.00455 |
GO:0005677 | chromatin silencing complex | 3.77% (2/53) | 5.88 | 0.00053 | 0.00455 |
GO:0008542 | visual learning | 3.77% (2/53) | 5.88 | 0.00053 | 0.00455 |
GO:0003690 | double-stranded DNA binding | 18.87% (10/53) | 1.78 | 0.000547 | 0.004669 |
GO:0007632 | visual behavior | 3.77% (2/53) | 5.83 | 0.000574 | 0.004828 |
GO:0035066 | positive regulation of histone acetylation | 3.77% (2/53) | 5.83 | 0.000574 | 0.004828 |
GO:0048536 | spleen development | 3.77% (2/53) | 5.83 | 0.000574 | 0.004828 |
GO:0048609 | multicellular organismal reproductive process | 13.21% (7/53) | 2.27 | 0.000578 | 0.004834 |
GO:0001541 | ovarian follicle development | 3.77% (2/53) | 5.77 | 0.00062 | 0.005086 |
GO:0080182 | histone H3-K4 trimethylation | 3.77% (2/53) | 5.77 | 0.00062 | 0.005086 |
GO:0002443 | leukocyte mediated immunity | 3.77% (2/53) | 5.77 | 0.00062 | 0.005086 |
GO:0006349 | regulation of gene expression by genomic imprinting | 3.77% (2/53) | 5.77 | 0.00062 | 0.005086 |
GO:0048468 | cell development | 11.32% (6/53) | 2.5 | 0.000653 | 0.005313 |
GO:0051253 | negative regulation of RNA metabolic process | 15.09% (8/53) | 2.04 | 0.000651 | 0.005316 |
GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines | 3.77% (2/53) | 5.72 | 0.000667 | 0.005321 |
GO:0071339 | MLL1 complex | 3.77% (2/53) | 5.72 | 0.000667 | 0.005321 |
GO:2000758 | positive regulation of peptidyl-lysine acetylation | 3.77% (2/53) | 5.72 | 0.000667 | 0.005321 |
GO:0007129 | homologous chromosome pairing at meiosis | 3.77% (2/53) | 5.72 | 0.000667 | 0.005321 |
GO:0030437 | ascospore formation | 3.77% (2/53) | 5.67 | 0.000715 | 0.005632 |
GO:0036314 | response to sterol | 3.77% (2/53) | 5.67 | 0.000715 | 0.005632 |
GO:0060216 | definitive hemopoiesis | 3.77% (2/53) | 5.67 | 0.000715 | 0.005632 |
GO:0031399 | regulation of protein modification process | 13.21% (7/53) | 2.21 | 0.000733 | 0.005741 |
GO:0003006 | developmental process involved in reproduction | 32.08% (17/53) | 1.17 | 0.000745 | 0.005812 |
GO:0045893 | positive regulation of DNA-templated transcription | 16.98% (9/53) | 1.85 | 0.000768 | 0.005884 |
GO:0120162 | positive regulation of cold-induced thermogenesis | 3.77% (2/53) | 5.62 | 0.000766 | 0.005894 |
GO:0022413 | reproductive process in single-celled organism | 3.77% (2/53) | 5.62 | 0.000766 | 0.005894 |
GO:1901985 | positive regulation of protein acetylation | 3.77% (2/53) | 5.62 | 0.000766 | 0.005894 |
GO:1903508 | positive regulation of nucleic acid-templated transcription | 16.98% (9/53) | 1.83 | 0.00082 | 0.006252 |
GO:1902680 | positive regulation of RNA biosynthetic process | 16.98% (9/53) | 1.83 | 0.000826 | 0.006272 |
GO:0031062 | positive regulation of histone methylation | 5.66% (3/53) | 4.02 | 0.00085 | 0.006425 |
GO:0009892 | negative regulation of metabolic process | 22.64% (12/53) | 1.49 | 0.000864 | 0.006504 |
GO:0007338 | single fertilization | 3.77% (2/53) | 5.53 | 0.000872 | 0.006534 |
GO:0008584 | male gonad development | 3.77% (2/53) | 5.48 | 0.000927 | 0.006919 |
GO:1902494 | catalytic complex | 16.98% (9/53) | 1.8 | 0.000953 | 0.007079 |
GO:0048145 | regulation of fibroblast proliferation | 3.77% (2/53) | 5.44 | 0.000984 | 0.00722 |
GO:0035371 | microtubule plus-end | 3.77% (2/53) | 5.44 | 0.000984 | 0.00722 |
GO:0009566 | fertilization | 5.66% (3/53) | 3.95 | 0.000982 | 0.007268 |
GO:0070577 | lysine-acetylated histone binding | 3.77% (2/53) | 5.4 | 0.001043 | 0.007555 |
GO:0140033 | acetylation-dependent protein binding | 3.77% (2/53) | 5.4 | 0.001043 | 0.007555 |
GO:0140657 | ATP-dependent activity | 11.32% (6/53) | 2.37 | 0.001049 | 0.007565 |
GO:0046914 | transition metal ion binding | 15.09% (8/53) | 1.94 | 0.001038 | 0.007581 |
GO:0043412 | macromolecule modification | 28.3% (15/53) | 1.24 | 0.001057 | 0.007589 |
GO:0120161 | regulation of cold-induced thermogenesis | 3.77% (2/53) | 5.36 | 0.001103 | 0.007732 |
GO:0042800 | histone methyltransferase activity (H3-K4 specific) | 3.77% (2/53) | 5.36 | 0.001103 | 0.007732 |
GO:0043935 | sexual sporulation resulting in formation of a cellular spore | 3.77% (2/53) | 5.36 | 0.001103 | 0.007732 |
GO:0004185 | serine-type carboxypeptidase activity | 3.77% (2/53) | 5.36 | 0.001103 | 0.007732 |
GO:0043565 | sequence-specific DNA binding | 18.87% (10/53) | 1.65 | 0.001097 | 0.007846 |
GO:0032409 | regulation of transporter activity | 7.55% (4/53) | 3.14 | 0.001102 | 0.007854 |
GO:0045740 | positive regulation of DNA replication | 3.77% (2/53) | 5.32 | 0.001165 | 0.008037 |
GO:0005703 | polytene chromosome puff | 3.77% (2/53) | 5.32 | 0.001165 | 0.008037 |
GO:0044665 | MLL1/2 complex | 3.77% (2/53) | 5.32 | 0.001165 | 0.008037 |
GO:0046872 | metal ion binding | 26.42% (14/53) | 1.29 | 0.001173 | 0.008055 |
GO:0010558 | negative regulation of macromolecule biosynthetic process | 15.09% (8/53) | 1.91 | 0.001155 | 0.008065 |
GO:0019538 | protein metabolic process | 30.19% (16/53) | 1.17 | 0.0012 | 0.008212 |
GO:0048608 | reproductive structure development | 13.21% (7/53) | 2.09 | 0.001214 | 0.008272 |
GO:0018023 | peptidyl-lysine trimethylation | 3.77% (2/53) | 5.28 | 0.001229 | 0.008277 |
GO:0055092 | sterol homeostasis | 3.77% (2/53) | 5.28 | 0.001229 | 0.008277 |
GO:0008217 | regulation of blood pressure | 3.77% (2/53) | 5.28 | 0.001229 | 0.008277 |
GO:1990837 | sequence-specific double-stranded DNA binding | 16.98% (9/53) | 1.74 | 0.001272 | 0.008531 |
GO:0048168 | regulation of neuronal synaptic plasticity | 3.77% (2/53) | 5.2 | 0.001361 | 0.008823 |
GO:1990752 | microtubule end | 3.77% (2/53) | 5.2 | 0.001361 | 0.008823 |
GO:0070008 | serine-type exopeptidase activity | 3.77% (2/53) | 5.2 | 0.001361 | 0.008823 |
GO:0010709 | heteroduplex formation involved in double-strand break repair via synthesis-dependent strand annealing | 1.89% (1/53) | 9.53 | 0.001356 | 0.008888 |
GO:0004159 | dihydropyrimidine dehydrogenase (NAD+) activity | 1.89% (1/53) | 9.53 | 0.001356 | 0.008888 |
GO:0000406 | double-strand/single-strand DNA junction binding | 1.89% (1/53) | 9.53 | 0.001356 | 0.008888 |
GO:0022619 | generative cell differentiation | 1.89% (1/53) | 9.53 | 0.001356 | 0.008888 |
GO:1903866 | palisade mesophyll development | 1.89% (1/53) | 9.53 | 0.001356 | 0.008888 |
GO:0051053 | negative regulation of DNA metabolic process | 5.66% (3/53) | 3.8 | 0.001333 | 0.008906 |
GO:0008340 | determination of adult lifespan | 5.66% (3/53) | 3.77 | 0.001406 | 0.009079 |
GO:0043169 | cation binding | 26.42% (14/53) | 1.26 | 0.001465 | 0.009426 |
GO:1901360 | organic cyclic compound metabolic process | 33.96% (18/53) | 1.04 | 0.001487 | 0.00953 |
GO:0140030 | modification-dependent protein binding | 5.66% (3/53) | 3.73 | 0.001534 | 0.009794 |
GO:0006974 | cellular response to DNA damage stimulus | 11.32% (6/53) | 2.26 | 0.001556 | 0.009897 |
GO:0031152 | aggregation involved in sorocarp development | 3.77% (2/53) | 5.1 | 0.001572 | 0.009963 |
GO:0140297 | DNA-binding transcription factor binding | 7.55% (4/53) | 3.0 | 0.001589 | 0.010034 |
GO:0045892 | negative regulation of DNA-templated transcription | 13.21% (7/53) | 2.02 | 0.001615 | 0.01016 |
GO:0048873 | homeostasis of number of cells within a tissue | 3.77% (2/53) | 5.07 | 0.001645 | 0.01024 |
GO:0001523 | retinoid metabolic process | 3.77% (2/53) | 5.07 | 0.001645 | 0.01024 |
GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity | 7.55% (4/53) | 2.99 | 0.001637 | 0.010259 |
GO:0051254 | positive regulation of RNA metabolic process | 16.98% (9/53) | 1.69 | 0.001684 | 0.010444 |
GO:0031327 | negative regulation of cellular biosynthetic process | 15.09% (8/53) | 1.82 | 0.001744 | 0.010778 |
GO:0031061 | negative regulation of histone methylation | 3.77% (2/53) | 5.0 | 0.001797 | 0.010947 |
GO:1902751 | positive regulation of cell cycle G2/M phase transition | 3.77% (2/53) | 5.0 | 0.001797 | 0.010947 |
GO:0045787 | positive regulation of cell cycle | 7.55% (4/53) | 2.95 | 0.001785 | 0.010954 |
GO:0050794 | regulation of cellular process | 49.06% (26/53) | 0.75 | 0.001785 | 0.010991 |
GO:0032452 | histone demethylase activity | 3.77% (2/53) | 4.97 | 0.001875 | 0.011344 |
GO:0140457 | protein demethylase activity | 3.77% (2/53) | 4.97 | 0.001875 | 0.011344 |
GO:0031400 | negative regulation of protein modification process | 7.55% (4/53) | 2.92 | 0.001925 | 0.011606 |
GO:0030518 | intracellular steroid hormone receptor signaling pathway | 3.77% (2/53) | 4.94 | 0.001955 | 0.011623 |
GO:0050681 | nuclear androgen receptor binding | 3.77% (2/53) | 4.94 | 0.001955 | 0.011623 |
GO:0051571 | positive regulation of histone H3-K4 methylation | 3.77% (2/53) | 4.94 | 0.001955 | 0.011623 |
GO:0004180 | carboxypeptidase activity | 3.77% (2/53) | 4.94 | 0.001955 | 0.011623 |
GO:0009890 | negative regulation of biosynthetic process | 15.09% (8/53) | 1.79 | 0.002038 | 0.012073 |
GO:0043229 | intracellular organelle | 60.38% (32/53) | 0.6 | 0.002087 | 0.012241 |
GO:0050804 | modulation of chemical synaptic transmission | 5.66% (3/53) | 3.57 | 0.002085 | 0.012269 |
GO:0099177 | regulation of trans-synaptic signaling | 5.66% (3/53) | 3.57 | 0.002085 | 0.012269 |
GO:0009952 | anterior/posterior pattern specification | 3.77% (2/53) | 4.88 | 0.00212 | 0.012387 |
GO:0031058 | positive regulation of histone modification | 5.66% (3/53) | 3.55 | 0.002182 | 0.012708 |
GO:0010557 | positive regulation of macromolecule biosynthetic process | 16.98% (9/53) | 1.62 | 0.002319 | 0.013464 |
GO:0008306 | associative learning | 3.77% (2/53) | 4.8 | 0.002378 | 0.013758 |
GO:0003713 | transcription coactivator activity | 5.66% (3/53) | 3.46 | 0.002597 | 0.014975 |
GO:0008703 | 5-amino-6-(5-phosphoribosylamino)uracil reductase activity | 1.89% (1/53) | 8.53 | 0.00271 | 0.01512 |
GO:0008835 | diaminohydroxyphosphoribosylaminopyrimidine deaminase activity | 1.89% (1/53) | 8.53 | 0.00271 | 0.01512 |
GO:0046443 | FAD metabolic process | 1.89% (1/53) | 8.53 | 0.00271 | 0.01512 |
GO:0032143 | single thymine insertion binding | 1.89% (1/53) | 8.53 | 0.00271 | 0.01512 |
GO:0032181 | dinucleotide repeat insertion binding | 1.89% (1/53) | 8.53 | 0.00271 | 0.01512 |
GO:0032301 | MutSalpha complex | 1.89% (1/53) | 8.53 | 0.00271 | 0.01512 |
GO:0032302 | MutSbeta complex | 1.89% (1/53) | 8.53 | 0.00271 | 0.01512 |
GO:0043111 | replication fork arrest | 1.89% (1/53) | 8.53 | 0.00271 | 0.01512 |
GO:0008406 | gonad development | 3.77% (2/53) | 4.72 | 0.002651 | 0.015182 |
GO:0003008 | system process | 9.43% (5/53) | 2.39 | 0.002644 | 0.015193 |
GO:0051568 | histone H3-K4 methylation | 3.77% (2/53) | 4.69 | 0.002745 | 0.015264 |
GO:0001046 | core promoter sequence-specific DNA binding | 3.77% (2/53) | 4.67 | 0.00284 | 0.015694 |
GO:0048569 | post-embryonic animal organ development | 3.77% (2/53) | 4.67 | 0.00284 | 0.015694 |
GO:1901987 | regulation of cell cycle phase transition | 7.55% (4/53) | 2.76 | 0.002881 | 0.015868 |
GO:0006081 | cellular aldehyde metabolic process | 5.66% (3/53) | 3.4 | 0.002939 | 0.016134 |
GO:0043227 | membrane-bounded organelle | 54.72% (29/53) | 0.63 | 0.002954 | 0.01617 |
GO:0035067 | negative regulation of histone acetylation | 3.77% (2/53) | 4.62 | 0.003036 | 0.016564 |
GO:0016810 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds | 5.66% (3/53) | 3.37 | 0.003099 | 0.016852 |
GO:0045005 | DNA-templated DNA replication maintenance of fidelity | 3.77% (2/53) | 4.55 | 0.003341 | 0.018114 |
GO:0030261 | chromosome condensation | 3.77% (2/53) | 4.53 | 0.003446 | 0.018624 |
GO:0140053 | mitochondrial gene expression | 5.66% (3/53) | 3.29 | 0.003611 | 0.019455 |
GO:2000757 | negative regulation of peptidyl-lysine acetylation | 3.77% (2/53) | 4.48 | 0.00366 | 0.019658 |
GO:0070076 | histone lysine demethylation | 3.77% (2/53) | 4.44 | 0.00388 | 0.020776 |
GO:0003382 | epithelial cell morphogenesis | 1.89% (1/53) | 7.94 | 0.004062 | 0.020844 |
GO:0044848 | biological phase | 1.89% (1/53) | 7.94 | 0.004062 | 0.020844 |
GO:1990636 | reproductive senescence | 1.89% (1/53) | 7.94 | 0.004062 | 0.020844 |
GO:0002100 | tRNA wobble adenosine to inosine editing | 1.89% (1/53) | 7.94 | 0.004062 | 0.020844 |
GO:0032137 | guanine/thymine mispair binding | 1.89% (1/53) | 7.94 | 0.004062 | 0.020844 |
GO:0032139 | dinucleotide insertion or deletion binding | 1.89% (1/53) | 7.94 | 0.004062 | 0.020844 |
GO:0032142 | single guanine insertion binding | 1.89% (1/53) | 7.94 | 0.004062 | 0.020844 |
GO:0032230 | positive regulation of synaptic transmission, GABAergic | 1.89% (1/53) | 7.94 | 0.004062 | 0.020844 |
GO:0035253 | ciliary rootlet | 1.89% (1/53) | 7.94 | 0.004062 | 0.020844 |
GO:0072383 | plus-end-directed vesicle transport along microtubule | 1.89% (1/53) | 7.94 | 0.004062 | 0.020844 |
GO:0072386 | plus-end-directed organelle transport along microtubule | 1.89% (1/53) | 7.94 | 0.004062 | 0.020844 |
GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation | 1.89% (1/53) | 7.94 | 0.004062 | 0.020844 |
GO:0051306 | mitotic sister chromatid separation | 1.89% (1/53) | 7.94 | 0.004062 | 0.020844 |
GO:0051309 | female meiosis chromosome separation | 1.89% (1/53) | 7.94 | 0.004062 | 0.020844 |
GO:0046184 | aldehyde biosynthetic process | 3.77% (2/53) | 4.4 | 0.004107 | 0.021009 |
GO:0016577 | histone demethylation | 3.77% (2/53) | 4.38 | 0.004222 | 0.021472 |
GO:0007613 | memory | 3.77% (2/53) | 4.38 | 0.004222 | 0.021472 |
GO:0008168 | methyltransferase activity | 7.55% (4/53) | 2.6 | 0.004304 | 0.021826 |
GO:0000976 | transcription cis-regulatory region binding | 15.09% (8/53) | 1.61 | 0.004328 | 0.02188 |
GO:0001067 | transcription regulatory region nucleic acid binding | 15.09% (8/53) | 1.6 | 0.004423 | 0.022294 |
GO:0048285 | organelle fission | 5.66% (3/53) | 3.16 | 0.004626 | 0.023253 |
GO:1901984 | negative regulation of protein acetylation | 3.77% (2/53) | 4.3 | 0.004699 | 0.023548 |
GO:0048519 | negative regulation of biological process | 30.19% (16/53) | 0.98 | 0.004713 | 0.023549 |
GO:0006482 | protein demethylation | 3.77% (2/53) | 4.28 | 0.004821 | 0.023885 |
GO:0008214 | protein dealkylation | 3.77% (2/53) | 4.28 | 0.004821 | 0.023885 |
GO:0001894 | tissue homeostasis | 3.77% (2/53) | 4.28 | 0.004821 | 0.023885 |
GO:0016741 | transferase activity, transferring one-carbon groups | 7.55% (4/53) | 2.55 | 0.004891 | 0.024161 |
GO:0031047 | gene silencing by RNA | 5.66% (3/53) | 3.12 | 0.005054 | 0.024895 |
GO:0006382 | adenosine to inosine editing | 1.89% (1/53) | 7.53 | 0.005413 | 0.024951 |
GO:0052717 | tRNA-specific adenosine-34 deaminase activity | 1.89% (1/53) | 7.53 | 0.005413 | 0.024951 |
GO:0032138 | single base insertion or deletion binding | 1.89% (1/53) | 7.53 | 0.005413 | 0.024951 |
GO:0048302 | regulation of isotype switching to IgG isotypes | 1.89% (1/53) | 7.53 | 0.005413 | 0.024951 |
GO:0048304 | positive regulation of isotype switching to IgG isotypes | 1.89% (1/53) | 7.53 | 0.005413 | 0.024951 |
GO:0005523 | tropomyosin binding | 1.89% (1/53) | 7.53 | 0.005413 | 0.024951 |
GO:0008090 | retrograde axonal transport | 1.89% (1/53) | 7.53 | 0.005413 | 0.024951 |
GO:0032253 | dense core granule localization | 1.89% (1/53) | 7.53 | 0.005413 | 0.024951 |
GO:0098957 | anterograde axonal transport of mitochondrion | 1.89% (1/53) | 7.53 | 0.005413 | 0.024951 |
GO:0099519 | dense core granule cytoskeletal transport | 1.89% (1/53) | 7.53 | 0.005413 | 0.024951 |
GO:0099641 | anterograde axonal protein transport | 1.89% (1/53) | 7.53 | 0.005413 | 0.024951 |
GO:1901950 | dense core granule transport | 1.89% (1/53) | 7.53 | 0.005413 | 0.024951 |
GO:1905150 | regulation of voltage-gated sodium channel activity | 1.89% (1/53) | 7.53 | 0.005413 | 0.024951 |
GO:1905152 | positive regulation of voltage-gated sodium channel activity | 1.89% (1/53) | 7.53 | 0.005413 | 0.024951 |
GO:1905383 | protein localization to presynapse | 1.89% (1/53) | 7.53 | 0.005413 | 0.024951 |
GO:1990049 | retrograde neuronal dense core vesicle transport | 1.89% (1/53) | 7.53 | 0.005413 | 0.024951 |
GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex | 1.89% (1/53) | 7.53 | 0.005413 | 0.024951 |
GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity | 1.89% (1/53) | 7.53 | 0.005413 | 0.024951 |
GO:2000653 | regulation of genetic imprinting | 1.89% (1/53) | 7.53 | 0.005413 | 0.024951 |
GO:0035264 | multicellular organism growth | 3.77% (2/53) | 4.19 | 0.005458 | 0.025023 |
GO:0051569 | regulation of histone H3-K4 methylation | 3.77% (2/53) | 4.19 | 0.005458 | 0.025023 |
GO:0048232 | male gamete generation | 5.66% (3/53) | 3.11 | 0.005109 | 0.025094 |
GO:0005700 | polytene chromosome | 3.77% (2/53) | 4.17 | 0.005589 | 0.025559 |
GO:0031328 | positive regulation of cellular biosynthetic process | 16.98% (9/53) | 1.44 | 0.005242 | 0.025674 |
GO:0046983 | protein dimerization activity | 13.21% (7/53) | 1.71 | 0.005278 | 0.025705 |
GO:0010467 | gene expression | 5.66% (3/53) | 3.09 | 0.005277 | 0.02577 |
GO:0042803 | protein homodimerization activity | 11.32% (6/53) | 1.88 | 0.00566 | 0.025815 |
GO:0048869 | cellular developmental process | 18.87% (10/53) | 1.34 | 0.005326 | 0.025863 |
GO:0047485 | protein N-terminus binding | 3.77% (2/53) | 4.15 | 0.005722 | 0.026029 |
GO:0009891 | positive regulation of biosynthetic process | 16.98% (9/53) | 1.42 | 0.005866 | 0.026544 |
GO:0043618 | regulation of transcription from RNA polymerase II promoter in response to stress | 3.77% (2/53) | 4.13 | 0.005857 | 0.026571 |
GO:0071345 | cellular response to cytokine stimulus | 5.66% (3/53) | 3.03 | 0.005919 | 0.026711 |
GO:0036211 | protein modification process | 22.64% (12/53) | 1.15 | 0.006104 | 0.027477 |
GO:0030098 | lymphocyte differentiation | 3.77% (2/53) | 4.05 | 0.006551 | 0.029334 |
GO:0008238 | exopeptidase activity | 3.77% (2/53) | 4.05 | 0.006551 | 0.029334 |
GO:0036292 | DNA rewinding | 1.89% (1/53) | 7.2 | 0.006762 | 0.029737 |
GO:0006119 | oxidative phosphorylation | 1.89% (1/53) | 7.2 | 0.006762 | 0.029737 |
GO:0030478 | actin cap | 1.89% (1/53) | 7.2 | 0.006762 | 0.029737 |
GO:0031340 | positive regulation of vesicle fusion | 1.89% (1/53) | 7.2 | 0.006762 | 0.029737 |
GO:0033333 | fin development | 1.89% (1/53) | 7.2 | 0.006762 | 0.029737 |
GO:0070410 | co-SMAD binding | 1.89% (1/53) | 7.2 | 0.006762 | 0.029737 |
GO:0098687 | chromosomal region | 5.66% (3/53) | 2.96 | 0.006801 | 0.029833 |
GO:1990823 | response to leukemia inhibitory factor | 3.77% (2/53) | 4.02 | 0.006838 | 0.029847 |
GO:1990830 | cellular response to leukemia inhibitory factor | 3.77% (2/53) | 4.02 | 0.006838 | 0.029847 |
GO:0034243 | regulation of transcription elongation by RNA polymerase II | 3.77% (2/53) | 4.03 | 0.006694 | 0.029897 |
GO:0008017 | microtubule binding | 5.66% (3/53) | 2.95 | 0.006933 | 0.030106 |
GO:0008134 | transcription factor binding | 7.55% (4/53) | 2.4 | 0.006926 | 0.030151 |
GO:0010948 | negative regulation of cell cycle process | 5.66% (3/53) | 2.95 | 0.006999 | 0.030319 |
GO:0048167 | regulation of synaptic plasticity | 3.77% (2/53) | 3.97 | 0.00728 | 0.031457 |
GO:0140110 | transcription regulator activity | 15.09% (8/53) | 1.48 | 0.00732 | 0.031551 |
GO:0032502 | developmental process | 43.4% (23/53) | 0.68 | 0.007375 | 0.031627 |
GO:0005694 | chromosome | 7.55% (4/53) | 2.38 | 0.007364 | 0.031658 |
GO:0003774 | cytoskeletal motor activity | 3.77% (2/53) | 3.94 | 0.007582 | 0.032355 |
GO:0007612 | learning | 3.77% (2/53) | 3.94 | 0.007582 | 0.032355 |
GO:0000217 | DNA secondary structure binding | 3.77% (2/53) | 3.93 | 0.007735 | 0.032927 |
GO:0033044 | regulation of chromosome organization | 5.66% (3/53) | 2.89 | 0.007757 | 0.03294 |
GO:0030491 | heteroduplex formation | 1.89% (1/53) | 6.94 | 0.008108 | 0.033283 |
GO:0004000 | adenosine deaminase activity | 1.89% (1/53) | 6.94 | 0.008108 | 0.033283 |
GO:0008251 | tRNA-specific adenosine deaminase activity | 1.89% (1/53) | 6.94 | 0.008108 | 0.033283 |
GO:0032405 | MutLalpha complex binding | 1.89% (1/53) | 6.94 | 0.008108 | 0.033283 |
GO:0099609 | microtubule lateral binding | 1.89% (1/53) | 6.94 | 0.008108 | 0.033283 |
GO:0030849 | autosome | 1.89% (1/53) | 6.94 | 0.008108 | 0.033283 |
GO:0001401 | SAM complex | 1.89% (1/53) | 6.94 | 0.008108 | 0.033283 |
GO:0000796 | condensin complex | 1.89% (1/53) | 6.94 | 0.008108 | 0.033283 |
GO:0016321 | female meiosis chromosome segregation | 1.89% (1/53) | 6.94 | 0.008108 | 0.033283 |
GO:0030334 | regulation of cell migration | 5.66% (3/53) | 2.88 | 0.0079 | 0.0333 |
GO:0030435 | sporulation resulting in formation of a cellular spore | 3.77% (2/53) | 3.91 | 0.007889 | 0.033337 |
GO:0035065 | regulation of histone acetylation | 3.77% (2/53) | 3.91 | 0.007889 | 0.033337 |
GO:0007389 | pattern specification process | 11.32% (6/53) | 1.77 | 0.007957 | 0.033458 |
GO:0051648 | vesicle localization | 3.77% (2/53) | 3.88 | 0.008202 | 0.033588 |
GO:0051650 | establishment of vesicle localization | 3.77% (2/53) | 3.9 | 0.008045 | 0.033746 |
GO:2000145 | regulation of cell motility | 5.66% (3/53) | 2.85 | 0.008338 | 0.034062 |
GO:1903131 | mononuclear cell differentiation | 3.77% (2/53) | 3.87 | 0.008361 | 0.034075 |
GO:0001666 | response to hypoxia | 7.55% (4/53) | 2.32 | 0.008391 | 0.034119 |
GO:2000756 | regulation of peptidyl-lysine acetylation | 3.77% (2/53) | 3.85 | 0.008521 | 0.034564 |
GO:0010629 | negative regulation of gene expression | 9.43% (5/53) | 1.97 | 0.008885 | 0.035957 |
GO:0004556 | alpha-amylase activity | 1.89% (1/53) | 6.72 | 0.009454 | 0.037041 |
GO:0019237 | centromeric DNA binding | 1.89% (1/53) | 6.72 | 0.009454 | 0.037041 |
GO:0032135 | DNA insertion or deletion binding | 1.89% (1/53) | 6.72 | 0.009454 | 0.037041 |
GO:0051096 | positive regulation of helicase activity | 1.89% (1/53) | 6.72 | 0.009454 | 0.037041 |
GO:0070692 | CTDK-1 complex | 1.89% (1/53) | 6.72 | 0.009454 | 0.037041 |
GO:0032228 | regulation of synaptic transmission, GABAergic | 1.89% (1/53) | 6.72 | 0.009454 | 0.037041 |
GO:0048246 | macrophage chemotaxis | 1.89% (1/53) | 6.72 | 0.009454 | 0.037041 |
GO:1905517 | macrophage migration | 1.89% (1/53) | 6.72 | 0.009454 | 0.037041 |
GO:0070176 | DRM complex | 1.89% (1/53) | 6.72 | 0.009454 | 0.037041 |
GO:1903754 | cortical microtubule plus-end | 1.89% (1/53) | 6.72 | 0.009454 | 0.037041 |
GO:1904511 | cytoplasmic microtubule plus-end | 1.89% (1/53) | 6.72 | 0.009454 | 0.037041 |
GO:0051307 | meiotic chromosome separation | 1.89% (1/53) | 6.72 | 0.009454 | 0.037041 |
GO:0032501 | multicellular organismal process | 32.08% (17/53) | 0.83 | 0.009524 | 0.037231 |
GO:0000123 | histone acetyltransferase complex | 3.77% (2/53) | 3.79 | 0.00934 | 0.037623 |
GO:0043620 | regulation of DNA-templated transcription in response to stress | 3.77% (2/53) | 3.79 | 0.00934 | 0.037623 |
GO:0008285 | negative regulation of cell population proliferation | 5.66% (3/53) | 2.78 | 0.009655 | 0.037657 |
GO:0032784 | regulation of DNA-templated transcription elongation | 3.77% (2/53) | 3.73 | 0.010021 | 0.038909 |
GO:2001252 | positive regulation of chromosome organization | 3.77% (2/53) | 3.73 | 0.010021 | 0.038909 |
GO:0006261 | DNA-templated DNA replication | 3.77% (2/53) | 3.72 | 0.010194 | 0.039493 |
GO:0005667 | transcription regulator complex | 5.66% (3/53) | 2.75 | 0.01023 | 0.039544 |
GO:0043167 | ion binding | 32.08% (17/53) | 0.82 | 0.010329 | 0.039749 |
GO:1901983 | regulation of protein acetylation | 3.77% (2/53) | 3.71 | 0.010369 | 0.039812 |
GO:0036293 | response to decreased oxygen levels | 7.55% (4/53) | 2.23 | 0.010324 | 0.03982 |
GO:0045786 | negative regulation of cell cycle | 5.66% (3/53) | 2.73 | 0.010483 | 0.040161 |
GO:0048872 | homeostasis of number of cells | 3.77% (2/53) | 3.69 | 0.010545 | 0.040309 |
GO:0031338 | regulation of vesicle fusion | 1.89% (1/53) | 6.53 | 0.010797 | 0.040731 |
GO:0071923 | negative regulation of cohesin loading | 1.89% (1/53) | 6.53 | 0.010797 | 0.040731 |
GO:0120186 | negative regulation of protein localization to chromatin | 1.89% (1/53) | 6.53 | 0.010797 | 0.040731 |
GO:0051747 | cytosine C-5 DNA demethylase activity | 1.89% (1/53) | 6.53 | 0.010797 | 0.040731 |
GO:0140078 | class I DNA-(apurinic or apyrimidinic site) endonuclease activity | 1.89% (1/53) | 6.53 | 0.010797 | 0.040731 |
GO:0000793 | condensed chromosome | 3.77% (2/53) | 3.68 | 0.010722 | 0.040896 |
GO:0051128 | regulation of cellular component organization | 15.09% (8/53) | 1.38 | 0.010899 | 0.041026 |
GO:0003824 | catalytic activity | 49.06% (26/53) | 0.57 | 0.011116 | 0.041751 |
GO:0010178 | IAA-amino acid conjugate hydrolase activity | 1.89% (1/53) | 6.36 | 0.012138 | 0.042883 |
GO:0010179 | IAA-Ala conjugate hydrolase activity | 1.89% (1/53) | 6.36 | 0.012138 | 0.042883 |
GO:0010210 | IAA-Phe conjugate hydrolase activity | 1.89% (1/53) | 6.36 | 0.012138 | 0.042883 |
GO:0010211 | IAA-Leu conjugate hydrolase activity | 1.89% (1/53) | 6.36 | 0.012138 | 0.042883 |
GO:1990206 | jasmonyl-Ile conjugate hydrolase activity | 1.89% (1/53) | 6.36 | 0.012138 | 0.042883 |
GO:0002566 | somatic diversification of immune receptors via somatic mutation | 1.89% (1/53) | 6.36 | 0.012138 | 0.042883 |
GO:0016446 | somatic hypermutation of immunoglobulin genes | 1.89% (1/53) | 6.36 | 0.012138 | 0.042883 |
GO:0045128 | negative regulation of reciprocal meiotic recombination | 1.89% (1/53) | 6.36 | 0.012138 | 0.042883 |
GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity | 1.89% (1/53) | 6.36 | 0.012138 | 0.042883 |
GO:0002228 | natural killer cell mediated immunity | 1.89% (1/53) | 6.36 | 0.012138 | 0.042883 |
GO:0007317 | regulation of pole plasm oskar mRNA localization | 1.89% (1/53) | 6.36 | 0.012138 | 0.042883 |
GO:0042267 | natural killer cell mediated cytotoxicity | 1.89% (1/53) | 6.36 | 0.012138 | 0.042883 |
GO:0044295 | axonal growth cone | 1.89% (1/53) | 6.36 | 0.012138 | 0.042883 |
GO:0098935 | dendritic transport | 1.89% (1/53) | 6.36 | 0.012138 | 0.042883 |
GO:0098937 | anterograde dendritic transport | 1.89% (1/53) | 6.36 | 0.012138 | 0.042883 |
GO:0002458 | peripheral T cell tolerance induction | 1.89% (1/53) | 6.36 | 0.012138 | 0.042883 |
GO:0002461 | tolerance induction dependent upon immune response | 1.89% (1/53) | 6.36 | 0.012138 | 0.042883 |
GO:0002465 | peripheral tolerance induction | 1.89% (1/53) | 6.36 | 0.012138 | 0.042883 |
GO:0002517 | T cell tolerance induction | 1.89% (1/53) | 6.36 | 0.012138 | 0.042883 |
GO:0060215 | primitive hemopoiesis | 1.89% (1/53) | 6.36 | 0.012138 | 0.042883 |
GO:0097536 | thymus epithelium morphogenesis | 1.89% (1/53) | 6.36 | 0.012138 | 0.042883 |
GO:2000410 | regulation of thymocyte migration | 1.89% (1/53) | 6.36 | 0.012138 | 0.042883 |
GO:1900039 | positive regulation of cellular response to hypoxia | 1.89% (1/53) | 6.36 | 0.012138 | 0.042883 |
GO:0030154 | cell differentiation | 13.21% (7/53) | 1.48 | 0.012235 | 0.043134 |
GO:0031248 | protein acetyltransferase complex | 3.77% (2/53) | 3.62 | 0.011629 | 0.043395 |
GO:1902493 | acetyltransferase complex | 3.77% (2/53) | 3.62 | 0.011629 | 0.043395 |
GO:0090329 | regulation of DNA-templated DNA replication | 3.77% (2/53) | 3.62 | 0.011629 | 0.043395 |
GO:0070482 | response to oxygen levels | 7.55% (4/53) | 2.16 | 0.0124 | 0.04354 |
GO:0002521 | leukocyte differentiation | 3.77% (2/53) | 3.57 | 0.012378 | 0.04355 |
GO:0015631 | tubulin binding | 5.66% (3/53) | 2.64 | 0.01254 | 0.043942 |
GO:0030182 | neuron differentiation | 3.77% (2/53) | 3.56 | 0.012568 | 0.043951 |
GO:0060249 | anatomical structure homeostasis | 3.77% (2/53) | 3.61 | 0.011814 | 0.043991 |
GO:0043231 | intracellular membrane-bounded organelle | 50.94% (27/53) | 0.55 | 0.011863 | 0.044076 |
GO:0034097 | response to cytokine | 5.66% (3/53) | 2.66 | 0.011891 | 0.044088 |
GO:0000781 | chromosome, telomeric region | 3.77% (2/53) | 3.53 | 0.013147 | 0.045882 |
GO:0060969 | obsolete negative regulation of gene silencing | 1.89% (1/53) | 6.2 | 0.013478 | 0.046013 |
GO:0031017 | exocrine pancreas development | 1.89% (1/53) | 6.2 | 0.013478 | 0.046013 |
GO:0008103 | oocyte microtubule cytoskeleton polarization | 1.89% (1/53) | 6.2 | 0.013478 | 0.046013 |
GO:0035617 | stress granule disassembly | 1.89% (1/53) | 6.2 | 0.013478 | 0.046013 |
GO:0046843 | dorsal appendage formation | 1.89% (1/53) | 6.2 | 0.013478 | 0.046013 |
GO:0002507 | tolerance induction | 1.89% (1/53) | 6.2 | 0.013478 | 0.046013 |
GO:0043383 | negative T cell selection | 1.89% (1/53) | 6.2 | 0.013478 | 0.046013 |
GO:0043971 | histone H3-K18 acetylation | 1.89% (1/53) | 6.2 | 0.013478 | 0.046013 |
GO:0043972 | histone H3-K23 acetylation | 1.89% (1/53) | 6.2 | 0.013478 | 0.046013 |
GO:0045060 | negative thymic T cell selection | 1.89% (1/53) | 6.2 | 0.013478 | 0.046013 |
GO:0046649 | lymphocyte activation | 3.77% (2/53) | 3.5 | 0.01354 | 0.046131 |
GO:0043473 | pigmentation | 3.77% (2/53) | 3.52 | 0.013343 | 0.046471 |
GO:0010090 | trichome morphogenesis | 3.77% (2/53) | 3.48 | 0.013937 | 0.047298 |
GO:0032922 | circadian regulation of gene expression | 3.77% (2/53) | 3.48 | 0.013937 | 0.047298 |
GO:0060042 | retina morphogenesis in camera-type eye | 1.89% (1/53) | 6.07 | 0.014816 | 0.048286 |
GO:0070691 | P-TEFb complex | 1.89% (1/53) | 6.07 | 0.014816 | 0.048286 |
GO:0070693 | P-TEFb-cap methyltransferase complex | 1.89% (1/53) | 6.07 | 0.014816 | 0.048286 |
GO:0001754 | eye photoreceptor cell differentiation | 1.89% (1/53) | 6.07 | 0.014816 | 0.048286 |
GO:0001909 | leukocyte mediated cytotoxicity | 1.89% (1/53) | 6.07 | 0.014816 | 0.048286 |
GO:0007526 | larval somatic muscle development | 1.89% (1/53) | 6.07 | 0.014816 | 0.048286 |
GO:0008345 | larval locomotory behavior | 1.89% (1/53) | 6.07 | 0.014816 | 0.048286 |
GO:0046530 | photoreceptor cell differentiation | 1.89% (1/53) | 6.07 | 0.014816 | 0.048286 |
GO:0099640 | axo-dendritic protein transport | 1.89% (1/53) | 6.07 | 0.014816 | 0.048286 |
GO:0002456 | T cell mediated immunity | 1.89% (1/53) | 6.07 | 0.014816 | 0.048286 |
GO:0045058 | T cell selection | 1.89% (1/53) | 6.07 | 0.014816 | 0.048286 |
GO:0045061 | thymic T cell selection | 1.89% (1/53) | 6.07 | 0.014816 | 0.048286 |
GO:0070412 | R-SMAD binding | 1.89% (1/53) | 6.07 | 0.014816 | 0.048286 |
GO:0098532 | histone H3-K27 trimethylation | 1.89% (1/53) | 6.07 | 0.014816 | 0.048286 |
GO:0010377 | guard cell fate commitment | 1.89% (1/53) | 6.07 | 0.014816 | 0.048286 |
GO:0035514 | DNA demethylase activity | 1.89% (1/53) | 6.07 | 0.014816 | 0.048286 |
GO:0007008 | outer mitochondrial membrane organization | 1.89% (1/53) | 6.07 | 0.014816 | 0.048286 |
GO:0045040 | protein insertion into mitochondrial outer membrane | 1.89% (1/53) | 6.07 | 0.014816 | 0.048286 |
GO:0000723 | telomere maintenance | 3.77% (2/53) | 3.43 | 0.014953 | 0.048365 |
GO:0032200 | telomere organization | 3.77% (2/53) | 3.43 | 0.014953 | 0.048365 |
GO:0051240 | positive regulation of multicellular organismal process | 9.43% (5/53) | 1.78 | 0.014887 | 0.048425 |
GO:0010638 | positive regulation of organelle organization | 5.66% (3/53) | 2.54 | 0.014918 | 0.048434 |
GO:0031969 | chloroplast membrane | 5.66% (3/53) | 2.56 | 0.014301 | 0.048439 |
GO:0007610 | behavior | 5.66% (3/53) | 2.56 | 0.014403 | 0.048593 |
GO:0009790 | embryo development | 11.32% (6/53) | 1.59 | 0.014375 | 0.048595 |
GO:0040012 | regulation of locomotion | 5.66% (3/53) | 2.53 | 0.015127 | 0.048837 |
GO:0003678 | DNA helicase activity | 3.77% (2/53) | 3.41 | 0.015368 | 0.049521 |
GO:1990234 | transferase complex | 9.43% (5/53) | 1.77 | 0.015495 | 0.049839 |